Dr. Taleb Taha, M.D

NPI: 1407161003
Total Payments
$1,049
2024 Payments
$219.10
Companies
17
Transactions
64
Medicare Patients
2,627
Medicare Billing
$333,847

Payment Breakdown by Category

Food & Beverage$1,049 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,049 64 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $197.91 12 $0 (2024)
PFIZER INC. $197.26 12 $0 (2024)
Novartis Pharmaceuticals Corporation $102.99 6 $0 (2024)
ABBVIE INC. $91.05 5 $0 (2024)
Lexicon Pharmaceuticals, Inc. $68.45 4 $0 (2024)
Allergan, Inc. $64.83 4 $0 (2020)
Gilead Sciences, Inc. $64.22 4 $0 (2024)
AstraZeneca Pharmaceuticals LP $57.87 4 $0 (2024)
Mylan Specialty L.P. $46.22 3 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $36.95 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $219.10 12 PFIZER INC. ($61.49)
2023 $266.07 16 Lexicon Pharmaceuticals, Inc. ($52.07)
2022 $82.86 5 Novartis Pharmaceuticals Corporation ($37.06)
2021 $84.61 5 Janssen Pharmaceuticals, Inc ($35.55)
2020 $104.81 7 PFIZER INC. ($43.48)
2019 $234.72 15 Janssen Pharmaceuticals, Inc ($68.74)
2017 $57.12 4 PFIZER INC. ($30.27)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/26/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $14.63 General
Category: COVID-19
11/20/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $19.58 General
Category: Obesity
11/14/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $13.43 General
Category: COVID-19
10/22/2024 ABBVIE INC. TEFLARO (Drug) Food and Beverage In-kind items and services $25.93 General
Category: ANTI-INFECTIVE
10/14/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $19.38 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/24/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $20.11 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/18/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.34 General
Category: Cardiovascular and Metabolism
06/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.55 General
Category: Gastroenterology
05/16/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.63 General
Category: Cardiovascular & Metabolism
05/07/2024 Lexicon Pharmaceuticals, Inc. Food and Beverage In-kind items and services $16.38 General
04/12/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.14 General
Category: Cardiology/Vascular Diseases
01/15/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $22.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/28/2023 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $17.87 General
Category: COVID-19
11/26/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $22.38 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/16/2023 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $18.29 General
Category: COVID-19
11/15/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $16.51 General
Category: Rare Disease
11/14/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $20.34 General
Category: DIABETES
09/15/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $15.22 General
Category: Inhibitor of SGLT2 and SGLT1
08/21/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $23.44 General
Category: Inhibitor of SGLT2 and SGLT1
08/02/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $13.41 General
Category: Inhibitor of SGLT2 and SGLT1
06/22/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $18.43 General
Category: Cardiology/Vascular Diseases
06/13/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $13.01 General
Category: Rare Disease
06/09/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $14.74 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/02/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $12.91 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/07/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $16.77 General
Category: ANTI-INFECTIVE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 716 920 $315,752 $95,805
2022 12 600 801 $247,190 $76,662
2021 11 661 1,023 $230,298 $74,404
2020 8 650 942 $256,369 $86,976
Total Patients
2,627
Total Services
3,686
Medicare Billing
$333,847
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 346 360 $173,160 $48,249 27.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 163 297 $78,300 $27,074 34.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 98 100 $27,056 $8,853 32.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 50 104 $18,207 $6,402 35.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 48 48 $15,648 $4,388 28.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 11 11 $3,381 $839.30 24.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 174 177 $85,137 $25,995 30.5%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 91 92 $40,388 $12,506 31.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 72 215 $36,980 $11,789 31.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 81 132 $32,736 $10,383 31.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 45 45 $11,970 $3,696 30.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 27 27 $8,802 $2,635 29.9%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 27 27 $8,721 $2,273 26.1%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 16 16 $6,512 $2,197 33.7%
99226 Follow-up observation care per day, typically 35 minutes Facility 2022 17 20 $4,980 $1,609 32.3%
99217 Hospital observation care on day of discharge Facility 2022 24 24 $4,152 $1,366 32.9%
99284 Emergency department visit for problem of high severity Facility 2022 15 15 $4,172 $1,357 32.5%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 11 11 $2,640 $855.49 32.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 155 380 $65,016 $21,359 32.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 95 146 $35,852 $11,534 32.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 73 73 $34,959 $11,478 32.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 118 121 $32,186 $9,856 30.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 39 39 $12,614 $4,060 32.2%
99220 Hospital observation care, typically 70 minutes Facility 2021 28 28 $12,244 $3,886 31.7%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 43 113 $10,493 $3,422 32.6%

About Dr. Taleb Taha, M.D

Dr. Taleb Taha, M.D is a Hospitalist healthcare provider based in Bismarck, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407161003.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taleb Taha, M.D has received a total of $1,049 in payments from pharmaceutical and medical device companies, with $219.10 received in 2024. These payments were reported across 64 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,049).

As a Medicare-enrolled provider, Taha has provided services to 2,627 Medicare beneficiaries, totaling 3,686 services with total Medicare billing of $333,847. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Hospitalist
  • Other Specialties Family Medicine
  • Location Bismarck, ND
  • Active Since 08/09/2010
  • Last Updated 07/30/2025
  • Taxonomy Code 208M00000X
  • Entity Type Individual
  • NPI Number 1407161003

Products in Payments

  • XARELTO (Drug) $197.91
  • ELIQUIS (Drug) $197.26
  • ENTRESTO (Drug) $86.59
  • DALVANCE (Drug) $82.08
  • TEFLARO (Drug) $73.80
  • Veklury (Drug) $64.22
  • Inpefa (Drug) $52.07
  • Yupelri (Drug) $46.22
  • JARDIANCE (Drug) $36.95
  • FARXIGA (Drug) $31.44
  • ULTOMIRIS (Biological) $29.52
  • BRILINTA (Drug) $26.43
  • Wegovy (Drug) $19.58
  • XIFAXAN (Drug) $19.55
  • LEQVIO (Drug) $16.40
  • PNEUMOVAX 23 (Biological) $16.13
  • Vabomere (Drug) $14.91
  • NUPLAZID (Drug) $11.13
  • Veltassa (Drug) $10.72

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hospitalist Doctors in Bismarck